Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Yeast Infection Treatment Market Size from 2025 to 2034?
The market for treating yeast infections has seen significant growth in the last few years. The market size is projected to grow from $4.33 billion in 2024 to $4.62 billion in 2025, showcasing a compound annual growth rate (CAGR) of 6.8%. This growth during the historical period can be credited to the rising occurrence of yeast infections, increased understanding of fungal infections, an aging population, global escalation of healthcare expenditure, as well as the development and approval of new antifungal medications.
Expectations suggest that the yeast infection treatment market will experience robust growth in the upcoming years, projecting its value to reach $5.74 billion in 2029, with a compound annual growth rate (CAGR) of 5.6%. This increase throughout the forecast period can be attributed to several factors. These include the rising endorsement of telemedicine for consultations from remote locations, tailoring medical treatments for individual needs, the introduction of combined treatment modalities for improved effectiveness, an increased focus on natural and herbal remedies, and a concentration on microbiome-focused therapy strategies for dealing with infections. Key trends for the forecast period encompass progress in genomic studies, the creation of small and precise diagnostic instruments, technological progress in diagnosing and treating yeast infections, an upsurge in research and development investments, and strategic alliances.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13958&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Yeast Infection Treatment Market?
Anticipated growth in the yeast infection treatment market is linked to an increasing prevalence of autoimmune diseases. These conditions cause the body’s immune system to mistakenly attack healthy cells, tissues and organs, impairing functionality and potentially becoming fatal. Yeast infection treatments play a crucial role in managing and preventing complications associated with autoimmune diseases. They do this by treating recurring yeast infections associated with certain autoimmune syndromes and by potentially moderating the immune response through treating fungal infections in autoimmune patients. For example, research by the US-based National Institutes of Health predicted that 8.4 million individuals globally would have type 1 diabetes in 2021, a figure suggesting an increase of 500,000 new cases in that year alone. Furthermore, expectations suggest between 13.5 and 17.4 million people will have type 1 diabetes by 2040. Consequently, the growing incidence of autoimmune diseases is contributing to the expansion of the yeast infection treatment market.
Which Key Market Segments Comprise the Yeast Infection Treatment Market and Drive Its Revenue Growth?
The yeast infection treatmentmarket covered in this report is segmented –
1) By Type: Powders; Creams Or Ointments; Tablets Or Capsules; Other Types
2) By Treatment: Medical Treatment; Surgery
3) By Indication: Genital Candidiasis; Invasive Candidiasis; Oropharyngeal Or Esophageal Candidiasis (Thrush); Other Indications
4) By Route Of Administration: Oral; Topical; IV (Intravenous) Or IM (Intramuscular); Other Routes Of Administration
5) By Application: Retail Pharmacies Or Drug Stores; Hospital Pharmacies; Specialty Stores; Online Sales; Other Applications
Subsegments:
1) By Powders: Antifungal Powders; Medicated Body Powders
2) By Creams Or Ointments: Antifungal Creams; Vaginal Ointments; Topical Creams
3) By Tablets Or Capsules: Oral Antifungal Tablets; Probiotic Capsules; Vaginal Tablets
4) By Other Types: Suppositories; Sprays; Gels
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13958&type=smp
Which Areas Are Leading Regions in the Yeast Infection Treatment Market Expansion Across the Globe?
North America was the largest region in the yeast infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yeast infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theYeast Infection Treatment Market Over the Coming Years?
Leading corporations in the yeast infection treatment market are concentrating on the launch of novel solutions or drugs, including non-azole oral antifungals, to maintain a competitive advantage. A non-azole oral antifungal is a medicine administered orally to combat fungal infections, but does not fall into the azole group of antifungals. For example, in December 2022, SCYNEXIS, a US biotechnology firm, received approval from the United States Food and Drug Administration (FDA), a US federal agency, for the second usage of BREXAFEMME (ibrexafungerp tablets). This new non-azole oral antifungal is the first FDA-authorized treatment used for both curing vaginal yeast infection, or vulvovaginal candidiasis (VVC), and lessening recurrent VVC occurrences. This innovative solution provides a unique alternative with wide-ranging efficacy, thus influencing the yeast infection treatment market trends and addressing the need for more treatment options for patients with recurrent VVC. The prescribed dosage of BREXAFEMME for VVC treatment is 300 mg (two 150 mg tablets), taken once a day, approximately 12 hours apart, which amounts to 600 mg (four 150 mg tablets) daily.
View the full report here:
https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report
How Is the Yeast Infection Treatment Market Conceptually Defined?
Yeast infection treatment is a medication employed to address and resolve infections caused by the overgrowth of the Candida fungus, commonly known as a yeast infection. These infections, known as candidiasis or yeast infections, can occur in various parts of the body, including the mouth (oral thrush), genitals (vaginal yeast infection), skin, and other mucous. They are used to relieve the symptoms of a yeast infection.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13958
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model